Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Creager

Showing results (111-120 of 292) with videos related to

Pageof 30
Sort By:
Journal of the American Heart Association|October 8, 2021
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 TrialIan C Gilchrist, David A Morrow, Mark A Creager, et al.
Vascular Medicine (London, England)|August 9, 2015
COCATS 4 Task Force 9: Training in Vascular Medicine: Endorsed by the Society for Vascular MedicineMark A Creager, Heather L Gornik, Bruce H Gray, et al.
Journal of Vascular Surgery|November 25, 2006
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryChristopher D Owens, Paul M Ridker, Michael Belkin, et al.
Journal of the American College of Cardiology|March 18, 2015
COCATS 4 Task Force 9: Training in Vascular MedicineMark A Creager, Heather L Gornik, Bruce H Gray, et al.
Vascular Medicine (London, England)|March 22, 2015
Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndromeAmi B Bhatt, J Stewart Buck, Jonah P Zuflacht, et al.
Circulation|January 31, 2016
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)Marc P Bonaca, J Antonio Gutierrez, Mark A Creager, et al.
Circulation|November 23, 2005
Atherosclerosis 2005: recent discoveries and novel hypothesesPascal J Goldschmidt-Clermont, Mark A Creager, Douglas W Losordo, et al.
The International Journal of Cardiovascular Imaging|December 15, 2007
Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imagingFrank John Rybicki, Dimitrios Mitsouras, Christopher D Owens, et al.
Vascular Medicine (London, England)|April 12, 2024
The impact of the Affordable Care Act Medicaid Expansion in Medicare beneficiaries with peripheral artery diseaseStanislav Henkin, Stephen A Kearing, Pablo Martinez-Camblor, et al.
Journal of the American College of Cardiology|June 20, 2006
Family history of diabetes is a major determinant of endothelial functionAllison B Goldfine, Joshua A Beckman, Rebecca A Betensky, et al.
Pageof 30

Showing results (111-120 of 292) with videos related to

Sort By:
Pageof 30
Journal of the American Heart Association|October 8, 2021
Efficacy and Safety of Vorapaxar by Intensity of Background Lipid-Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P-TIMI 50 TrialIan C Gilchrist, David A Morrow, Mark A Creager, et al.
Vascular Medicine (London, England)|August 9, 2015
COCATS 4 Task Force 9: Training in Vascular Medicine: Endorsed by the Society for Vascular MedicineMark A Creager, Heather L Gornik, Bruce H Gray, et al.
Journal of Vascular Surgery|November 25, 2006
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgeryChristopher D Owens, Paul M Ridker, Michael Belkin, et al.
Journal of the American College of Cardiology|March 18, 2015
COCATS 4 Task Force 9: Training in Vascular MedicineMark A Creager, Heather L Gornik, Bruce H Gray, et al.
Vascular Medicine (London, England)|March 22, 2015
Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndromeAmi B Bhatt, J Stewart Buck, Jonah P Zuflacht, et al.
Circulation|January 31, 2016
Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50)Marc P Bonaca, J Antonio Gutierrez, Mark A Creager, et al.
Circulation|November 23, 2005
Atherosclerosis 2005: recent discoveries and novel hypothesesPascal J Goldschmidt-Clermont, Mark A Creager, Douglas W Losordo, et al.
The International Journal of Cardiovascular Imaging|December 15, 2007
Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imagingFrank John Rybicki, Dimitrios Mitsouras, Christopher D Owens, et al.
Vascular Medicine (London, England)|April 12, 2024
The impact of the Affordable Care Act Medicaid Expansion in Medicare beneficiaries with peripheral artery diseaseStanislav Henkin, Stephen A Kearing, Pablo Martinez-Camblor, et al.
Journal of the American College of Cardiology|June 20, 2006
Family history of diabetes is a major determinant of endothelial functionAllison B Goldfine, Joshua A Beckman, Rebecca A Betensky, et al.
Pageof 30